// App-Quantinova.ai

PB0620 : Low molecular weight heparin slows the formation of clots from patients within twenty-four hours of acute PE

Researchers

Presenter

  • S. Baker

Principal Investigators

  • G. Halliday

  • R. Arins

Medical Centers

  • Wake Forest University Medical Center, Winston Salem, North Carolina, United States

  • University of Leeds, Leeds, United Kingdom

  • Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A